Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 13,312

Document Document Title
WO/2016/054544A1
Disclosed are steviol glycosides referred to as rebaudioslde V and rebaudioslde W. Also disclosed are methods for producing rebaudioslde M (Reb M), rebausoside G (Reb G)', rebaudioslde KA (Reb KA), rebaudioslde V (Reb V) and rebaudioslde...  
WO/2016/051187A1
There are provided compounds of formula I, wherein R1A to R1E, R2 to R4, R5a, L and X1 to X3 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: th...  
WO/2016/054281A2
A method for the purification of idraparinux sodium includes: passing a solution including a crude idraparinux sodium through a column including a sodium ion exchange resin to obtain a first mixture; passing a solution including the firs...  
WO/2016/054540A1
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside ...  
WO/2016/052488A1
[Problem] To provide a chelate compound that has a high safety and is applicable to various uses. [Solution] A chelate compound wherein a chelate-forming moiety is attached to a base compound having an amino group and at least a part of ...  
WO/2016/047428A1
[Problem] To provide a cyclic hemiacetal compound production method that is performed under mild conditions easily and at a high yield and that is superior in stereoselectivity and enables mass production. [Solution] Provided is a produc...  
WO/2016/046420A1
The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 8 capsular polysaccharide, conjugates thereof and the use of said saccharides and conjugates for raising ...  
WO/2016/049315A1
Stevia compositions are prepared from Stevia rebaudiana Bertoni extracts. The compositions are able to provide a superior taste profile and can be used as sweeteners, sweetness enhancers, flavors, flavor enhancers in foods, beverages, co...  
WO/2016/046419A1
The present invention relates to novel immunostimulatory molecules which are derived from the intestinal protozoan Entamoeba histolytica.The compounds have been found to be useful for enhancing and/or inducing an immune response in a sub...  
WO/2016/041698A1
Mixtures comprising a mixture of compounds (A), said mixture comprising a mixture of compounds according to the general formula (I) wherein R1 is C1 -C 4 -alkyl, linear or branched, or hydrogen, R 2 is -CH 2 CH2 R1, each G 1 is glucose o...  
WO/2016/043501A1
A method for preparing an anhydrosugar alcohol, according to the present invention, can increase the yield of the anhydrosugar alcohol even without adding a catalyst or with only a small amount of catalyst, by controlling the reaction te...  
WO/2016/038205A1
The invention relates to fluorescent conjugates of formula (I) (I) where CG is a carbohydrate compound selected from the monosaccharide residues, the oligosaccharides and the polyoligosaccharides comprising at least one monosaccharide re...  
WO/2016/038192A1
The present invention relates to a method for preparing 2'-O-fucosyllactose, the 2'-O-fucosyllactose obtainable by this method and the use thereof. The method comprises reacting the persilylated, protected fucose derivatives of the formu...  
WO/2016/040369A2
Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.  
WO/2016/034559A1
The present invention relates to a method for preparing marmycin A and analogues thereof, to novel marmycin A analogues, and also to the use of these compounds as an organelle marker and in pharmacy, in particular as antibiotics, antican...  
WO/2015/181834A4
The present invention relates to novel semi-synthetic meningococcal conjugate vaccine comprising novel synthetic oligosaccharide conjugated to a carrier protein. The present invention also relates to novel synthetic meningococcal oligosa...  
WO/2016/034942A1
A Stevia extract made from leaves of the Stevia rebaudiana plant is described. The extract has desired levels of steviol glycosides wherein any one or more of Rebaudioside D,E,N,0 is present a higher concentration and is useful in food, ...  
WO/2016/035221A1
The purpose of the present invention is to provide a peach extract obtained from peaches, said peach extract having an active oxygen-scavenging ability, and a highly safe method for producing the same. Provided is a peach extract having ...  
WO/2015/200514A3
Provided herein are compounds of the formulas: (I) wherein: n, X2, R3, R3', R4, R4', R5, R5', R6, and R6' are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used...  
WO/2016/026641A1
The invention relates to fatty acid polyester derivatives of polyglycosides and formed from a polyol comprising between 2 and 10 hydroxy functions, the 2 hydroxy functions or at least 2 of said hydroxy functions being attached to the ano...  
WO/2015/154074A9
A method is disclosed for synthesizing a compound that includes gallotannins from a part of a maple tree, into new skin whitening compounds. The method includes the step of isolating the gallotannin from the part of the maple tree.  
WO/2016/028233A1
The present invention provides a method for determining the presence of a microorganism in a sample using an electrochemically active reporter, wherein the method comprises (a) contacting the sample with an electrochemically active repor...  
WO/2015/189346A8
The invention relates to novel material mixtures which can be used as aromatic preparations to enhance the sweet taste of oral preparations.  
WO/2016/023103A1
A method for purifying Reb M includes preparing a crude mother liquor/Stevia rebaudiana primary extract, passing a solution of this primary extract through a multi-column system including a plurality of columns, in series, packed with a ...  
WO/2016/025790A1
Disclosed are UAP inhibitors to inhibit glucose flux in the hexosamine biohynthetic pathway and methods of treating a disease using the inhibitors.  
WO/2016/019630A1
Disclosed is a method for synthesizing 1,3-disubstituted allene with high optical activity, namely a method for preparing 1,3-disubstituted allene with high optical activity in one step of functionalizing terminal alkyne, aldehyde and ch...  
WO/2016/018024A1
The present invention relates to a crystalline composite comprising dapagliflozin and a method for preparing the same. More specifically, the present invention provides a novel crystalline composite comprising dapagliflozin, which is an ...  
WO/2015/181834A3
The present invention relates to novel semi-synthetic meningococcal conjugate vaccine comprising novel synthetic oligosaccharide conjugated to a carrier protein. The present invention also relates to novel synthetic meningococcal oligosa...  
WO/2016/004512A1
A synthetic charged glycolipid is described comprising a sulfated saccharide group covalently linked to the tree sn-1 hydroxyl group of the glycerol backbone of an archaeal core lipid via a beta linkage. The synthetic charged glycolipids...  
WO/2016/005311A1
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal...  
WO/2016/004704A1
Disclosed is a gastrodin production process comprising the preparation of acetoxymethyl phenol, the preparation of pentacetyl gastrodin, and the preparation and refining of gastrodin, including: stirring hydroxybenzyl alcohol, glacial ac...  
WO/2016/005340A1
The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of ...  
WO/2015/197377A1
The present invention relates to an alkyl glycoside sulfomethylsuccinate having the formula R1-O-Sn-R2 wherein R1 is an alkyl radical having 6 to 30 carbon atoms, S is a monosaccharide moiety, and R2 is a sulfomethylsuccinate moiety. Fur...  
WO/2015/200514A2
Provided herein are compounds of the formulas: (I) wherein: n, X2, R3, R3', R4, R4', R5, R5', R6, and R6' are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used...  
WO/2015/195713A1
The invention describes sweetening compositions and methods to prepare sweetening compositions containing steviol glycosides, salts, and other natural or synthetic sweeteners with improved solubilities and sensory profiles.  
WO/2015/194199A1
[Problem] To provide a method for obtaining an alkyl-N-acetylglucosaminide with a low content of N-acetylglucosamine, which is an impurity, inexpensively, easily, and efficiently. [Solution] This method for producing an alkyl-N-acetylglu...  
WO/2015/190489A1
 The purpose of the present invention is to provide a useful prodrug compound of a naphthofuran compound. The present invention pertains to a compound represented by general formula (IA): (the symbols in the formula are as stated in th...  
WO/2015/189346A1
The invention relates to novel material mixtures which can be used as aromatic preparations to enhance the sweet taste of oral preparations.  
WO/2015/185675A1
The present invention relates to an apparatus and method for separating glycoglycerolipids and also glycoglycerolipids and glycosphingolipids from a lipid phase that contains glycoglycerolipids and acyl glycerides or glycoglycerolipids a...  
WO/2015/187040A1
The invention relates to amino sphingoglycolipid analogues and peptide derivatives thereof, compositions comprising these compounds and methods of treating or preventing diseases or conditions using such compounds, especially diseases or...  
WO/2015/185676A1
The present invention relates to an apparatus and method for separating glycoglycerolipids and also glycoglycerolipids and glycosphingolipids from a lipid phase that contains glycoglycerolipids and acyl glycerides or glycoglycerolipids a...  
WO/2015/184451A1
Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the trunca...  
WO/2015/177668A1
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting a...  
WO/2015/003082A3
The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus.  
WO/2015/178265A1
It was discovered that interposing a suitable aromatic amidation linker in making a prodrug to serve as a γ-glutamylation drug provides stability even in a close to physiological environment, recognition by GGT, and very rapid release o...  
WO/2015/168779A1
A method for purifying Mogroside V comprises passing a solution of a pre-prepared Siraitia grosvenori primary extract through a multi-column system including a plurality of columns, in series, packed with a porous adsorbent resin to prov...  
WO/2015/171944A1
The present invention provides edible compositions comprising a compound of the present invention, food products comprising such edible compositions and methods of preparing such food products. The present invention also provides methods...  
WO/2015/171555A1
Disclosed is a steviol glycoside referred to as rebaudioside D2. Rebaudioside D2 has five β-D-glucosyl units connected to the aglycone steviol. Also disclosed are methods for producing rebaudioside D2, a UDP-glycosyltransferase fusion e...  
WO/2015/166016A1
The present invention relates to a method for purifying epidaunorubicin, in particular to the removal of the impurity epi-feudomycin such as is formed as a by-product in the biotechnological production of epidaunorubicin.  
WO/2015/168514A1
Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing ...  

Matches 401 - 450 out of 13,312